On November 11, Aehr Test saw an Overnight rise of 8.14%, trading at $64.42, with turnover of $0.8298 million.
The move followed continued market focus on the company’s stronger-than-expected quarterly results, raised full-year revenue outlook, and ongoing progress in AI chip testing orders and deployment.
Previously disclosed results showed adjusted EPS of $0.28 versus expectations of $0.11, while revenue reached $33.007 million versus $27.072 million expected. Backlog stood at $100.9 million as of September 25. The company also highlighted progress with a major AI accelerator customer, including deployment tied to wafer-level burn-in testing and a fully configured FOX-XP unit planned for installation at a partner facility in Taiwan in early 2027, reinforcing AI-related demand as the central trading catalyst.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments